Directory
>
John Lippincott
John Lippincott
Senior Vice President Therapeutic Discovery Strategies | Alloy Therapeutics, Inc.
San Diego, California, United States
John Lippincott
Summary
John Lippincott is a seasoned executive with over 20 years of experience in therapeutic discovery strategies, currently serving as the Senior Vice President at Alloy Therapeutics. He has a strong background in antibody generation and characterization, having led significant projects at Pfizer and other biotechnology firms. Lippincott's expertise spans various aspects of biopharmaceuticals, including drug discovery and clinical development. He holds a Ph.D. from Harvard University, where he specialized in Cell Biology. Notably, he has a track record of building and leading high-performing teams in competitive environments. His innovative approach has contributed to advancements in therapeutic candidates and antibody discovery platforms. Lippincott's career reflects a commitment to enhancing the scientific community's ability to develop effective medicines.
John Lippincott
Work Experience
Senior Vice President Therapeutic Discovery Strategies at
Alloy Therapeutics, Inc.
April 2023 - Present
Senior Vice President of Therapeutic Discovery Strategies at
AlivaMab Biologics
July 2022 - March 2023
Vice President of Research at
AlivaMab Biologics
March 2018 - July 2022
Consultant at
Ablexis, LLC
January 2015 - December 2021
Vice President of Antibody Discovery at
Lakepharma, Inc., Now Part Of Curia
February 2016 - March 2018
Director of Research Operations at
Ablexis, LLC
March 2012 - January 2015
Director of Antibody Discovery at
IGENICA LIMITED
May 2010 - March 2012
Senior Principal Scientist at
Pfizer, Inc.
July 2001 - May 2010
Postdoctoral Associate at
GNF
January 2000 - January 2001
John Lippincott
Education
Harvard Medical School, Ph.D.
January 1996 - January 2000
January 1993 - January 1996
January 1993 - January 1996
Frequently Asked Questions about John Lippincott
What is John Lippincott email address?
John Lippincott's primary email address is ***********@alivamab.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does John Lippincott work for?
John Lippincott is a Senior Vice President Therapeutic Discovery Strategies at Alloy Therapeutics, Inc., a company specializing in Commercial physical research.
Where John Lippincott graduated from?
John Lippincott holds a degree in Cell Biology from Harvard Medical School.
How can I directly contact John Lippincott?
To contact John Lippincott directly, you can use the email address ***********@alivamab.com. Complete contact information is available upon registration with Muraena.
Who is John Lippincott?
John Lippincott is a seasoned executive with over 20 years of experience in therapeutic discovery strategies, currently serving as the Senior Vice President at Alloy Therapeutics. He has a strong background in antibody generation and characterization, having led significant projects at Pfizer and other biotechnology firms. Lippincott's expertise spans various aspects of biopharmaceuticals, including drug discovery and clinical development. He holds a Ph.D. from Harvard University, where he specialized in Cell Biology. Notably, he has a track record of building and leading high-performing teams in competitive environments. His innovative approach has contributed to advancements in therapeutic candidates and antibody discovery platforms. Lippincott's career reflects a commitment to enhancing the scientific community's ability to develop effective medicines.
John`s contact details
***********@alivamab.com
***************@alloytx.com
*****@post.harvard.edu
Colleagues
General Partner
CTO, TCR Discovery and Engineering at Alloy Therapeutics | Founder and CEO at Keyway TCR Discovery
Vice President of Daedamab Business Development
Harvard Business Review Advisory Council Member
VP Head of Protein Science & Bioanalytics